InvestorsHub Logo
Followers 827
Posts 119469
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Friday, 11/09/2018 6:58:30 PM

Friday, November 09, 2018 6:58:30 PM

Post# of 866
FDA approves Keytruda monotherapy for second-line HCC:

https://finance.yahoo.com/news/fda-approves-merck-keytruda-pembrolizumab-212100345.html

This is an accelerated approval based on ORR (17%) and duration of response in the single-arm KEYNOTE-224 study. Patients were either refractory to, or ineligible for, Nexavar, or had Child-Pugh-A cirrhosis. Today is the PDUFA date.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News